Hasil Pencarian - Carol Sze Ki Leung

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

    Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy oleh Federica Cappuccini, Emily Pollock, Irina Redchenko, Benoit J Van den Eynde, James McAuliffe, Hok Fung Chan, Laurine Noblecourt, Ramiro Andrei Ramirez-Valdez, Vinnycius Pereira-Almeida, Yaxuan Zhou, Adrian VS Hill, Carol Sze Ki Leung

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression

    Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression oleh Ramiro A. Ramirez-Valdez, Faezzah Baharom, Ahad Khalilnezhad, Sloane C. Fussell, Dalton J. Hermans, Alexander M. Schrager, Kennedy K.S. Tobin, Geoffrey M. Lynn, Shabnam Khalilnezhad, Florent Ginhoux, Benoit J. Van den Eynde, Carol Sze Ki Leung, Andrew S. Ishizuka, Robert A. Seder

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice

    Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice oleh Benoit J Van den Eynde, Maryam Ahmad, James McAuliffe, Laurine Noblecourt, Ramiro Andrei Ramirez-Valdez, Vinnycius Pereira-Almeida, Carol Sze Ki Leung, Vincent Stroobant, Amanda Wicki, Silvia Panetti, Emily Steffke, Yushu Hu, Shi Yu William Guo, Julie Lesenfants, Vineethkrishna Chandrasekar, Nathalie Vigneron

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: